Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas.

Alessandro Del GobboAlessio PellegrinelliGabriella GaudiosoMassimo CastellaniFederica Zito MarinoRenato FrancoAlessandro PalleschiMario NosottiSilvano BosariValentina VairaStefano Ferrero

Published in: Histopathology (2015)

Our results highlight how tumour heterogeneity influences evaluation of prognostic biomarkers. Our data support Ki67 evaluation to estimate NSCLC patients' prognosis, particularly for adenocarcinoma.

Keyphrases